Biotech VC Eyes Record Year after Strong Q3

The dollar value and number of biopharma venture capital deals continue at a potentially record clip heading into the final quarter of 2017.Investors raised $2.221 billion in 102 biotech VC deals during the third quarter, according to the most recent quarterly PwC/CB Insights MoneyTree™ Report, released Wednesday.That’s 12% less in dollars, and almost flat in number of deals, compared with the $2.516 billion in 104 deals recorded in Q3 2016. But the third quarter finished 36% higher